SCHEMBL6605375

SCHEMBL6605375

Cc1ccc(Nc2nccc(-c3c(C)c(C#N)n(-n4c(C)c(-c5ccnc(Nc6ccc(C)c([N+](=O)[O-])c6)n5)c(C)c4C#N)c3C)n2)cc1I

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 13/20 0.62
CDK4 P11802 11/20 0.62
ALDH1A1 P00352 2/20 0.44
NPC1 O15118 1/20 0.36
MAPT P10636 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
PLK1 P53350 1/20 0.36
IKBKB O14920 1/20 0.35
ABL1 P00519 3/20 0.35
BCR P11274 2/20 0.35
PRKCA P17252 2/20 0.35
AURKA O14965 1/20 0.35
CCNT1 O60563 1/20 0.35
CCNB2 O95067 1/20 0.35
CCNE2 O96020 1/20 0.35
CDK1 P06493 1/20 0.35
CCNB1 P14635 1/20 0.35
CCNA2 P20248 1/20 0.35
CCND1 P24385 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6599378 0.84 CDK4 (0.45) CDK2CDK4PLK1GSK3BAURKB
SCHEMBL6605374 0.83 CDK2 (0.90) CDK2CDK4ALDH1A1
SCHEMBL6668845 0.80 CDK4 (0.74) CDK2CDK4ALDH1A1IKBKBGSK3B
SCHEMBL4613610 0.77 CDK2 (0.58) CDK2CDK4ALDH1A1PLK1IKBKB
SCHEMBL4615866 0.77 CDK2 (1.00) CDK2CDK4ALDH1A1
SCHEMBL6279175 0.77 CDK2 (0.61) CDK2CDK4ALDH1A1NPC1MAPT
SCHEMBL6601086 0.74 CDK2 (0.58) CDK2CDK4PLK1CCNT1CDK1
SCHEMBL6600190 0.74 CDK4 (0.58) CDK2CDK4PLK1GSK3BAURKB
SCHEMBL6600211 0.74 CDK4 (0.58) CDK2CDK4PLK1GSK3BAURKB
SCHEMBL6597472 0.73 CDK2 (0.49) CDK2CDK4IKBKBABL1BCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1373253-A1 INHIBITORS OF CYCLIN DEPENDENT KINASES AS ANTI-CANCER AGENT Cyclacel Limited (GB) 2004-01-02 EP claimed
WO-2002079193-A1 INHIBITORS OF CYCLIN DEPENDENT KINASES AS ANTI-CANCER AGENT CYCLACEL LIMITED (GB) 2002-10-10 WO claimed